CBC Group, Asia’s largest healthcare-dedicated investment firm, is committed to creating value and integrating global resources. Partnering with the world’s top entrepreneurs and scientists, its unique “investor-operator” approach has empowered global leading healthcare companies to widen access to affordable medical care, catalyze innovations, and improve efficiency in fulfilling unmet medical needs worldwide. Founded in 2014, CBC has a leading team of investment, industry and portfolio management professionals headquartered in Singapore with offices in Shanghai, Beijing, Hong Kong and New York, and presences in Boston, San Diego, San Francisco, and Tokyo. CBC focuses on platform-building, buyout, credit and growth-focused opportunities across multiple core areas within the healthcare sector, including pharmaceutical and biotech, medical technology and healthcare services.
Location: Singapore
Employees: 51-200
Founded date: 2014
Investment Type: Venture Capital
Portfolio 16
| Date | Name | Website | Total Raised | Location |
| - | Fujian Her... | berrygenomics.com | - | China, Bei... |
| - | Anrei Medi... | anreimedical.medincn.com | - | - |
| - | Lu Daopei ... | ludaopei.com | - | - |
| - | 济川药业... | jumpcan.com | - | China, Jia... |
| - | I-Mab Biop... | i-mabbiopharma.com | $678M | - |
| - | fitomedical.net | - | - | |
| - | cq-pharm.com | - | - | |
| - | å京æ±å... | njjbrmyy.net | - | - |
| - | Clarus The... | clarustherapeutics.com | $30M | Canada, On... |
| - | CMAB Bioph... | cmabbio.com | $72M | - |
Show more
News 34
| Date | Title | Description |
| 25.12.2021 | Penn mRNA Biology Pioneer Drew Weissman Joins RVAC's Science Advisory Board | Sep.30, 2021 RVAC Medicines Pte. Ltd. ("RVAC"), an emerging messenger RNA (mRNA) platform company in Singapore aspiring to address various diseases with unmet medical needs for emerging markets through novel vaccines and ther... |
| 25.12.2021 | CBC-backed Jadeite Medicines Announces Exclusive Licensing Agreement with Albireo Pharma to Develop and Promote Odevixibat in Japan | Oct.12, 2021 Agreement to accelerate the development and commercialization of odevixibat in Japan, a significant market for PFIC, Alagille syndrome and biliary atresia Bylvay TM (odevixibat) approved in U.S., EU and UK with global presc... |
| 16.06.2021 | Deal focus: NiKang pursues hard-to-drug targets | Tim Burroughs 01 June 2021 Healthcare investor CBC Group is best known for backing start-ups that license nascent treatments from the US and develop drugs for the China market. Everest Medicines, a biotech player incubated by CBC, leverag... |
| - | Everest Medicines Appoints Kerry Blanchard, M.D., Ph.D., as Director and Chief Executive Officer | SHANGHAI, China, Feb. 20, 2020 (GLOBE NEWSWIRE) -- Everest Medicines, a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products that address critical unmet medical needs for patients in Gre... |
| - | Everest Medicines Completes US$310 Million Series C Financing | SHANGHAI, China, June 04, 2020 (GLOBE NEWSWIRE) -- Everest Medicines, a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products that address critical unmet medical needs for patients in Gre... |
| - | I-Mab Biopharma Announces Dosing of First Patient in a Pivotal Study of TJ202/MOR202 in Multiple Myeloma in Mainland China | SHANGHAI, Jan. 3, 2020 /PRNewswire/ -- I-Mab Biopharma ("I-Mab"), a global biopharmaceutical company based in China and the United States and focused on the discovery and development of novel or highly differentiated biologics in ... |
| - | Nuance Pharma Closes Series D Financing | NEWS PROVIDED BY Nuance Pharma Dec 08, 2020, 04:24 ET SHARE THIS ARTICLE SHANGHAI, Dec. 8, 2020 /PRNewswire/ -- Nuance Pharma, a biopharmaceutical company engaged in creating value through China's specialty pharmaceutical markets ... |
| - | Immunomedics and Everest Medicines Announce Exclusive License Agreement for Sacituzumab Govitecan in East and Southeast Asia Excluding Japan | MORRIS PLAINS, N.J. and NEW YORK, April 29, 2019 (GLOBE NEWSWIRE) -- Immunomedics, Inc., (NASDAQ: IMMU) (“Immunomedics” or the “Company”), a leading biopharmaceutical company in the area of antibody-drug conjugates (ADC) and Everest Medicin... |
| - | I-Mab Appoints Leading Immunology and Hematology Experts to Its Scientific Advisory Board | SHANGHAI and GAITHERSBURG, Md., Dec. 1, 2020 /PRNewswire/ -- I-Mab (the "Company") (Nasdaq: IMAB), a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel biologics, today ... |
| - | Everest Medicines Achieved First Patient Dosing Milestone in Etrasimod Phase 3 Clinical Study in Ulcerative Colitis Patients in Asia | NEW YORK, Nov. 14, 2019 (GLOBE NEWSWIRE) -- Everest Medicines, a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products that address critical unmet medical needs for patients in Greater Ch... |
Show more
Mentions in press and media 33
| Date | Title | Description |
| 04.07.2024 | CBC Group's Hasten Biopharmaceutical Expands Portfolio with Celltrion Legacy Products | CBC Group's Hasten Biopharmaceutical, backed by CBC's unique "investor-operator" model, acquires 14 branded products from Celltrion, marking a strategic move towards international expansion and growth in the healthcare sector. In ... |
| 01.07.2024 | CBC-Backed Hasten Biopharmaceutical Announces Acquisition of 14 Celltrion Legacy Products | The deal leverages CBC's hands-on "investor-operator" approach to accelerate portfolio companies' asset acquisition and strategic international expansion SINGAPORE, July 1, 2024 /PRNewswire/ -- CBC Group ("CBC"), Asia's ... |
| 30.06.2024 | CBC-Backed Hasten Biopharmaceutical Announces Acquisition of 14 Celltrion Legacy Products | The deal leverages CBC's hands-on "investor-operator" approach to accelerate portfolio companies' asset acquisition and strategic international expansion SINGAPORE, June 30, 2024 /PRNewswire/ -- CBC Group ("CBC"), Asia's... |
| 28.06.2024 | Hasten Announces Acquisition of 14 Celltrion Legacy Products, Accelerating its Business Expansion in the Pan-Asia Area | SHANGHAI, June 28, 2024 /PRNewswire/ -- Hasten Biopharmaceutical Co., Ltd. (referred to as "Hasten") announced today that it has successfully acquired the asset rights of 14 branded products across Pan-Asia countries and regions f... |
| 04.06.2024 | CBC Group Rises to 104th Position in the 2024 PEI 300 Global List | • Ranked Singapore's largest and Asia's 7th largest private equity firm[1] • Ranked Asia's largest healthcare-dedicated private equity firm[1] • CBC has been in the ranks for the last six consecutive years SINGAPORE, June 4, 2024 /PRNewswir... |
| 04.06.2024 | CBC Group Rises to 104th Position in the 2024 PEI 300 Global List | • Ranked Singapore's largest and Asia's 7th largest private equity firm[1] • Ranked Asia's largest healthcare-dedicated private equity firm[1] • CBC has been in the ranks for the last six consecutive years SINGAPORE, June 4, 2024 /PRNewswir... |
| 01.06.2023 | CBC GROUP RELEASES 2022 ESG REPORT | Guided by the firm's commitment to drive positive and meaningful impact while delivering better healthcare for all SINGAPORE, June 1, 2023 /PRNewswire/ -- CBC Group ("CBC"), Asia's largest healthcare-dedicated investment firm, tod... |
| 04.05.2023 | Hasten Biopharma Acquires Commercial Rights in China for Roche's Antibiotic Rocephin® | The acquisition will deliver strong commercial synergy with Hasten's current critical care portfolio SHANGHAI, May 4, 2023 /PRNewswire/ -- Hasten Biopharmaceutic Co., Ltd (China) ("Hasten") today announced that it has acquired the... |
| 20.04.2023 | CBC GROUP AND MUBADALA CO-LEAD US$315 MILLION FUNDRAISING ROUND FOR HASTEN BIOPHARMA | Proceeds raised will be used to fund future acquisitions, and fuel business development of innovative pipeline assets SINGAPORE, April 20, 2023 /PRNewswire/ -- CBC Group ("CBC"), Asia's largest healthcare-dedicated investment firm... |
| 01.04.2023 | CBC Group Appoints Healthcare Veteran Abbas Hussain as Operating Partner | SINGAPORE, April 1, 2023 /PRNewswire/ -- Singapore-headquartered asset management firm, CBC Group ("CBC"), is pleased to announce the appointment of healthcare industry veteran, Abbas Hussain, as Operating Partner. In this role, A... |
Show more